ERBB2 and neoplasm: In addition, they support the idea that the low cytotoxicity induced by ACE preparations from Ova-4 and Ova-5 HER-2/neu− primary tumours should rather be attributed to an inadequate recognition of tumour targets than to qualitative differences in cytokine secretion profiles by the MEAMNC effectors.